Low-fat diet reduces female pancreatic cancer risk

Share This Post

Investigative research suggests that diet may affect the risk of pancreatic cancer. The study investigated the effect of a low-fat diet on the incidence of pancreatic cancer.

The Women’s Healthy Diet Changes (WHI-DM) trial is a randomized controlled trial that included 48,835 postmenopausal women aged 50 to 79 years between 1993 and 1998. The enrolled women were randomly assigned to the intervention group (19,541 cases) with the goal of reducing their total fat intake and increasing the intake of vegetables, fruits, and grains; or the normal diet control group (29,294 cases). The intervention group was completed in March 2005. Through the application of log-rank test and multifactor Cox risk proportional model follow-up in 2014, the effect of dietary intervention on the incidence of pancreatic cancer was evaluated.

Intentional analysis included 46 200 women, 92 patients in the intervention group and 165 patients in the control group were diagnosed with pancreatic cancer (P = 0.23), multivariate analysis, the intervention group compared with the control group of pancreatic cancer risk ratio HR) is 0.86 (95% CI 0.67 ~ 1.11). For subjects with a baseline body mass index (BMI) of 25 kg / m2 or more, intervention can reduce the risk of pancreatic cancer (HR = 0.71, 95% CI 0.53 ~ 0.96). Intervention did not significantly reduce the risk of morbidity (HR = 1.62, 95% CI 0.97 ~ 2.71; P = 0.01). 

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Gamma Delta T Cell therapy in Malaysia
CAR T-Cell therapy

Gamma Delta T Cell Therapy in Malaysia: A Revolution in Cancer Treatment

Gamma Delta T Cell therapy is revolutionizing cancer treatment by harnessing the immune system’s power. This innovative approach is gaining momentum in Malaysia, a rising medical hub in Southeast Asia. With cutting-edge facilities, cost-effective treatments, and strong government support, Malaysia is advancing this therapy to offer hope to cancer patients. By focusing on research and international collaborations, the country is poised to lead the region in next-generation cancer care.

Gamma Delta T Cell therapy in Sinagpore
CAR T-Cell therapy

Gamma Delta T Cell Therapy in Singapore: A Revolutionary Approach for Late-Stage Cancer Treatment

Gamma Delta (GD) T Cell therapy is revolutionizing stage 4 cancer treatment, offering hope to metastatic cancer patients. At Singapore’s National University Hospital (NUH), the ANGELICA trials harness the unique tumor-targeting abilities of GD T cells. This cutting-edge therapy minimizes side effects, enhances survival rates, and improves quality of life. As a global leader in medical innovation, Singapore positions itself as a premier destination for advanced cancer therapies like GD T Cell therapy.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy